Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »

Healthy Food Makes You Happy: Research Shows A Healthy Diet Improves Your Mental Health – Forbes

Young woman buying fresh red peppers at supermarket. She’s picking peppers from the shelf.Getty Depression has many origins: genetic, triggered by a specific event or circumstance or lifestyle choices. But it is a disease of the brain, and researchers are finding that ensuring it receives the proper nutrients is a way to treat depression. In… Read More »